Evidence map›Paper›PMID 29540766›Full record

ArticleScientific reports2018

Loss of ezrin expression reduced the susceptibility to the glomerular injury in mice.

Ryo Hatano, Ai Takeda, Yukiko Abe, Kotoku Kawaguchi, Itsuro Kazama, Mitsunobu Matsubara, Shinji Asano

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. UsingFrontiers in cell and developmental biology · 2022
    Review
  5. Renal cell markers: lighthouses for managing renal diseases.American journal of physiology. Renal physiology · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ryo HatanoDepartment of Molecular Physiology, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan. hatanori@fc.ritsumei.ac.jp.
Ai TakedaDepartment of Molecular Physiology, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
Yukiko AbeDepartment of Molecular Physiology, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
Kotoku KawaguchiDepartment of Molecular Physiology, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.ORCID 0000-0001-9552-7494
Itsuro KazamaDepartment of Physiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Mitsunobu MatsubaraDivision of Molecular Medicine, Center for Translational and Advanced Animal Research, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Shinji AsanoDepartment of Molecular Physiology, College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
Ritsumeikan University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ezrin is highly expressed in glomerular podocytes and is reported to form a multi-protein complex with scaffold protein Na

Indexed as

Genetic Predisposition to DiseaseAnimalsBiomarkersCytoskeletal ProteinsDisease Models, AnimalEzrinFluorescent Antibody TechniqueGene ExpressionGenetic Association StudiesImmunohistochemistryKidney DiseasesKidney GlomerulusMiceMice, KnockoutPodocytesProtein TransportBiomarkersCytoskeletal ProteinsEzrin

Identifiers

PMID29540766
PMCPMC5852236
OpenAlexW2793375993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.